Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of the United States' insistence on confidential data.
The decision became public after a official document from December was leaked, which showed President Emmerson Mnangagwa deemed the agreement was "lopsided".
An official spokesman has since stated that the United States was requesting genetic material for research and commercial purposes while was unwilling to guarantee the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further negotiations to find a agreement suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Context
This rejection comes after a comparable case in Kenya, where a court blocked a similar health funding agreement after legal challenges were filed about the security of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
Based on reports, Sixteen nations in Africa have so far agreed to similar agreements, representing more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million presently on HIV treatment through American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent assurance of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," he stated.
"Put simply, our country would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our people if a new disease outbreak emerge."
National Interest and Global Health
He also said that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining structures already established via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This system is designed to ensure that when a country provides its samples, the benefits – such as medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how future co-operation might be designed in a way that honours the sovereignty and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but suggested that negotiations need to persist given that much of the nation's Aids initiatives were funded by foreign aid.
"In cases where specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.
The situation emphasises the complex tensions between accepting crucial international aid and safeguarding a country's data in an increasingly interconnected world.